![Jared Gollob](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 6 M $ in data 31/05/2026
Dr. Jared Gollob, MD, is a Chief Medical Officer at Kymera Therapeutics, Inc. Dr. Gollob was previously employed as a Global VP-Medical Affairs & Clinical Development by Alnylam Pharmaceuticals, Inc. and a Director-Biologic Therapy Program by Duke University.
He received his undergraduate degree from The Trustees of Columbia University in The City of New York and a doctorate degree from The Trustees of Columbia University in The City of New York.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 71.359 ( 0,09% ) | 6 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2018 |
| Società | Posizione | Fine |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2018 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/09/2007 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
